Colon Cancer Clinical Trial

Association Between Hepatitis C Infection and Renal Cell Carcinoma

Summary

The purpose of this study is to determine if there is an association between hepatitis C infection and kidney cancer. All patients who are diagnosed with kidney cancer and who will either have a biopsy or surgery will be offered to be tested for hepatitis C. The control group will be colon cancer patients. Both groups would be of recent diagnosis (6 months).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male and female patients 18 years or older in whom renal cell carcinoma is suspected and are scheduled for either biopsy or partial or total nephrectomy. Diagnosis within 6 months.
Male and female patients 18 years or older in whom colorectal cancer has been diagnosed within the last 6 months

Exclusion Criteria:

Patients who are unwilling to provide consent
Patients who decline to complete a questionnaire
Patient in who blood sample cannot be obtained
Diagnosis of renal cell carcinoma or colon cancer greater than 6 months

Study is for people with:

Colon Cancer

Estimated Enrollment:

240

Study ID:

NCT01405183

Recruitment Status:

Completed

Sponsor:

Henry Ford Health System

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Henry Ford Hospital
Detroit Michigan, 48202, United States

How clear is this clinincal trial information?

Study is for people with:

Colon Cancer

Estimated Enrollment:

240

Study ID:

NCT01405183

Recruitment Status:

Completed

Sponsor:


Henry Ford Health System

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider